Dermatitis, Atopic: all 1,443 studies

Page 3 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.

• Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerlandRecruitingNCT05819463
• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisEnrolling by invitationNCT05735483Phase 3
• A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their OffspringRecruitingNCT05721937
• Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic DermatitisRecruitingNCT05702268Phase 2
• Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With DupilumabRecruitingNCT05694884Phase 2
• A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.RecruitingNCT05689151
• A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic DermatitisRecruitingNCT05676242Phase 3
• Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis TherapyRecruitingNCT05674695
• Allergy and Immunology Natural History StudyRecruitingNCT05584488
• Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.RecruitingNCT05575882Not applicable
• Effects of Electroacupuncture to Relieve Itching Degree in Patients With Chronic Atopic EczemaNot yet recruitingNCT05529836Not applicable
• A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic DermatitisNot yet recruitingNCT05525715Phase 1/2
• Vitamin D Treatment Effect for Atopic Dermatitis in ChildrenRecruitingNCT05523986Not applicable
• The Effect of Intervention and Mechanism of ICBT on Chronic Itching in Patients With Atopic DermatitisNot yet recruitingNCT05502848Not applicable
• Meditation in Inflammatory DermatosisRecruitingNCT05500794Not applicable
• Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)AvailableNCT05466578
• Effects of a Mixed Chinese Herbal Formula on Atopic DermatitisNot yet recruitingNCT05455060Phase 3
• A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic DermatitisRecruitingNCT05391061
• Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.RecruitingNCT05330637
• Dupixent and Narrowband UVB for Atopic DermatitisRecruitingNCT05285839Phase 4
• Ethnic Differences in Mechanisms of Action of DupilumabRecruitingNCT05268107Phase 4
• SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis SubjectsRecruitingNCT05215808Phase 1
• Microbiome in Atopic Dermatitis Under Systemic TherapyRecruitingNCT05099315
• Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic DermatitisRecruitingNCT05042258Phase 4
• Characterization of Chronic Hand EczemaRecruitingNCT05026554
• Metabolic Profiling of Immune Responses in Immune-mediated DiseasesRecruitingNCT04864886
• Frequency of Palpebral Involvement in Adult With Atopic DermatitisRecruitingNCT04826744
• Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD InjNot yet recruitingNCT04730024
• A Prospective Sample Collection Study Using Non-invasive Methods to Investigate Biomarkers in AD PatientsRecruitingNCT04699695
• CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and EffectivenessRecruitingNCT04504955
• Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 PolymorphismRecruitingNCT04455906
• Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis ChildrenRecruitingNCT04419584Phase 2/3
• Deployment o the Multidisciplinary Prospective Cohort ImminentRecruitingNCT04334031Not applicable
• Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic DermatitisRecruitingNCT04307862Phase 2
• Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab TreatmentRecruitingNCT04276623
• Prospective Longitudinal Observational Research in Atopic DermatitisRecruitingNCT04240522
• Long-Term Safety Follow-Up Study of SCM-AGH in Subjects Who Participated and Administered SCM-AGH in to Severe Atopic Dermatitis Clinical TrialsEnrolling by invitationNCT04185584
• Skin Microbial Ecology in Atopic DermatitisRecruitingNCT04170244
• Expanded Access to UpadacitinibAvailableNCT04159597
• Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia AreataEnrolling by invitationNCT03976622
• Restoration of Microbiota in NeonatesRecruitingNCT03928431Not applicable
• Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic DermatitisRecruitingNCT03835767Phase 2
• TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)RecruitingNCT03795506Not applicable
• TREAT NL (TREatment of ATopic Eczema, the Netherlands) Registry: Dutch National Registry for Patients With Moderate-to-severe Atopic Eczema on Photo- or Systemic TherapiesRecruitingNCT03621137
• BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic DermatitisRecruitingNCT03549416
• Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and PsoriasisRecruitingNCT03361215
• Molecular Signatures in Inflammatory Skin DiseaseRecruitingNCT03358693
• TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic DermatitisRecruitingNCT03057860
• Natural History and Genetics of Food Allergy and Related ConditionsRecruitingNCT02504853
• Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD)RecruitingNCT02365246Phase 2
• Effects of Treatments on Atopic DermatitisRecruitingNCT01631617Phase 2
• Studies of Skin Microbes in Healthy People and in People With Skin ConditionsRecruitingNCT00605878
• Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis ResearchRecruitingNCT00177268
• Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.TerminatedNCT06447506Phase 2Results posted
• Lebrikizumab Pen Ease of Use in Participants With Atopic DermatitisCompletedNCT06444165Phase 3Results posted
• A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT06280716Phase 3Results posted
• A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy ParticipantsCompletedNCT06268860Phase 1Results posted
• A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic DermatitisCompletedNCT06238817Phase 3Results posted
• Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic DermatitisCompletedNCT06144424Phase 2Results posted
• A Study of LY3872386 in Healthy Participants and Participants With Atopic DermatitisTerminatedNCT06119529Phase 1Results posted
• Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe AD (Atopic Dermatitis)CompletedNCT06101823Phase 2Results posted
• A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic DermatitisTerminatedNCT05999799Phase 2Results posted
• Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic DermatitisCompletedNCT05990725Phase 3Results posted
• A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)TerminatedNCT05984784Phase 1/2Results posted
• A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic TherapyCompletedNCT05958407Phase 3Results posted
• POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic DermatitisCompletedNCT05932654Phase 2Results posted
• A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic DermatitisCompletedNCT05923099Phase 2Results posted
• A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic DermatitisTerminatedNCT05911841Phase 2Results posted
• A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)CompletedNCT05899816Phase 3Results posted
• A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic DermatitisCompletedNCT05870865Phase 2Results posted
• A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by InjectionTerminatedNCT05732454Phase 2/3Results posted
• A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)CompletedNCT05724199Phase 3Results posted
• A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)CompletedNCT05704738Phase 3Results posted
• The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.TerminatedNCT05696392Phase 4Results posted
• A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic DermatitisCompletedNCT05656911Phase 2Results posted
• A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)CompletedNCT05651711Phase 3Results posted
• A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)CompletedNCT05633355Phase 3Results posted
• A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT05601882Phase 3Results posted
• Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema TrialCompletedNCT05590585Phase 4Results posted
• Safety and Efficacy Study of EVO101 Topical Cream in Atopic DermatitisCompletedNCT05579899Phase 2Results posted
• A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT05507580Phase 4Results posted
• A Study of LY3844583 in Healthy Participants and Participants With Atopic DermatitisTerminatedNCT05486208Phase 1Results posted
• A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe ADCompletedNCT05470114Phase 2Results posted
• Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS)CompletedNCT05469464Phase 2Results posted
• Study of Ruxolitinib Cream in Adolescents With Atopic DermatitisCompletedNCT05456529Phase 3Results posted
• Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)CompletedNCT05450198Phase 1Results posted
• A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 TrialsTerminatedNCT05439941Phase 2Results posted
• Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin AnalysisCompletedNCT05436535Phase 4Results posted
• An Efficacy and Safety Study of RPT193 in Adults With Atopic DermatitisTerminatedNCT05399368Phase 2Results posted
• A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)CompletedNCT05398445Phase 3Results posted
• A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.CompletedNCT05375955Phase 2Results posted
• A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in IndiaCompletedNCT05375929Phase 3Results posted
• A Long-term Trial of OPA-15406 in Infants With Atopic DermatitisCompletedNCT05372653Phase 3Results posted
• A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of ColorCompletedNCT05372419Phase 3Results posted
• A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With DupilumabCompletedNCT05369403Phase 3Results posted
• Clinical Investigation on the Efficacy and Safety of Relizema Cream in Paedriatric PatientsCompletedNCT05259774Not applicableResults posted
• Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous GelTerminatedNCT05253755Phase 2Results posted
• A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic DermatitisTerminatedNCT05250115Results posted
• Improvement In Scratch Behavior And Sleep In Patients With Atopic DermatitisTerminatedNCT05200403Phase 4Results posted
• Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA)CompletedNCT05194540Phase 3Results posted

← Dermatitis, Atopic overview